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Abstract
Heidi Shaffer, OTR/L, MSM, CLT-LANA at MultiCare-Gig Harbor was interested in
how early intervention, namely intervening at Stage 0, related to better outcomes for oncology
patients at risk of lymphedema. This question was developed from a desire to follow-up prior
student research relating to the usefulness of the LDEX in lymphedema management, however
current literature did not indicate the LDEX as an early intervention method. Although the
authors did not exclude other types of cancer, the research only reflected breast cancer outcomes.
Overall, strong evidence was found that exercise is not contraindicated for clients at risk of
breast cancer related lymphedema (BCRL). There was strong evidence endorsing
implementation of surveillance models to increase early detection and early intervention of
BCRL. There was strong evidence that compression sleeves and decongestive therapy were
effective in treating BCRL. There was moderate evidence to suggest that exercise and early
intervention helped prevent the progression of BCRL. There was no evidence to the authors’
knowledge that surveillance methods were contraindicated for clients at risk of lymphedema.
Additionally, there was some evidence that treating lymphedema at a subclinical stage reduces
treatment time and inhibits the progression of lymphedema. In conclusion, surveillance methods
coupled with early intervention could be recommended by the authors to help prevent the
progression of lymphedema. These recommendations, if followed, may lead to reduced overall
healthcare costs and maintain a high quality of life for oncology patients.
Knowledge translation was conducted to support the dissemination of our findings. Our
knowledge translation included submitting an abstract to the International Lymphoedema
Framework Conference in the Netherlands. The authors created and proposed a template to track
outcomes of current and upcoming lymphedema clients. A PowerPoint was created and provided
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to Shaffer’s supervisor, Sherri Olsen OTD, MBA synthesizing our findings. The authors then had
an informed conversation with Olsen about their findings and the realistic application and
implementation of the findings into practice. The authors’ hope was that Olsen would
disseminate the information to a wider audience, specifically, providers who are responsible for
referring clients at risk of lymphedema to a lymphedema specialist, and other lymphedema
specialists who may benefit from this research. Future recommendations include synthesizing
outcome data collected by lymphedema specialists at MultiCare and further investigation of the
support systems for clients at risk of lymphedema.
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Executive Summary
This one-year effort began by collaboratively creating a practice question with
Heidi Shaffer, OTR/L, MSM, CLT-LANA of MultiCare in Gig Harbor, Washington.
Shaffer was interested in determining the extent to which early intervention impacts
outcomes for oncology patients at risk of lymphedema. The question arose from Shaffer’s
desire to increase her preventive care caseload. After an extensive literature search, the
author’s conclusions were that compression garments were supported in early intervention
to stop the progression of lymphedema. Additionally, neither exercise nor stretching were
contraindicated for those with or at risk of lymphedema, and there was strong evidence to
support surveillance methods as an approach to preventing the progression of lymphedema.
Furthermore, there was some research surrounding the negative impact the fear of
developing lymphedema has on a client’s quality of life. The implications of our findings
varied for consumers, practitioners, and researchers. For consumers, it is important to note
that exercise and movement do not increase the risk of lymphedema and know that the fear
of developing lymphedema may impact function more than physical limitations as a result
of progressing lymphedema. Future research should include quality of life measures for
clients with lymphedema as well as retrospective information regarding how the clients felt
about their intervention. Further research needs to be done on lymphedema related to other
types of cancer and where it impacts the lower extremities. The implications for
practitioners include referring clients at risk of lymphedema to a lymphedema specialist for
preventive care and knowing that exercise is not contraindicated for those at risk of
lymphedema. Additionally, practitioners should consider the emotional and psychological
aspects of lymphedema during their interventions, of particular focus to occupational
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therapy practitioners, but also applicable to any practitioner interacting with clients at risk
of lymphedema. Knowledge translation activities included 1) an abstract submission to the
International Lymphedema Framework conference, 2) creating a potential template for
tracking client outcomes, and 3) a presentation to Shaffer’s supervisor. The main outcome
of our knowledge translation activities was a consequence of our meeting with Shaffer’s
supervisor. This consisted of immediate feedback following our presentation as well as an
outcomes survey to be completed at a later time. The feedback from her consisted of her
stated plan to speak to an oncologist she knows to refer for prevention care at a higher rate
than most, discussion of plans for sharing the PowerPoint, and exploration of novel ideas
for the dissemination of information to lymphedema patients within the MultiCare system.
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Final CAT Paper, Revised
Focused Question:
To what extent does early intervention relate to better outcomes for oncology patients at
risk of lymphedema?
Collaborating Occupational Therapy Practitioner:
Heidi Shaffer, OTR/L, MSM, CLT-LANA

Prepared By:

Claire Brummet, Nicole Chang, and Kayleigh Odgear, OTS

Chair:
Jennifer Pitonyak, PhD, OTR/L, SCFES

Course Mentor:
George Tomlin, PhD, OTR/L, FAOTA

Date Review Completed:
5/05/18

Clinical Scenario:
Heidi was interested in learning more about early intervention of lymphedema and how it
impacts a client’s prognosis and the progression. Early intervention was defined as
having subclinical lymphedema or Stage 1 lymphedema at the start of treatment.
Furthermore, she was also interested in increasing her prevention caseload to help
reduce patient financial burden and monitor lymphedema progression.
Review Process
Procedures for the selection and appraisal of articles
Inclusion Criteria:
Oncology client or patient, any age, gender, and race, lymphedema measures taken
(circumferential, volumetric, perometry, bioimpedance), Articles in English (journal
translations allowed), any year of publication
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Exclusion Criteria:
Bilateral lymphedema, vascular related lymphedema, treatment started after Stage 3
lymphedema
Search Strategy
Categories

Key Search Terms

Patient/Client Population

Oncology clients/patients at risk of lymphedema

Intervention (Assessment)

Early intervention (patient education and
physical modalities) initiated by early detection
practices

Comparison

Current standards of practice

Outcomes

Stage of lymphedema, quality of life (via
questionnaire), pain, UE function (ADL
performance, A/PROM, strength), risk factors

Databases and Sites Searched
PubMed, CINAHL, and MEDLINE (EBSCO)

Quality Control/Review Process:
Claire:
Scan abstract for applicability to research question and investigate full article if abstract
does not provide enough information to determine applicability to the research question.
Created and managed database in Excel for article tracking and citation follow up.
Nicole:
Scan article to verify our inclusion criteria is met and no exclusion criteria present.
Find research question in article and read article once to understand it broadly. Read
again to pull out main themes.
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Observe how themes are changing as time progresses and as articles are found.
Kayleigh:
Input chosen articles into the CAT table as well as organized and formatted the CAT
table.

Results of Search
Table 1. Search Strategy of databases.
Search Terms

Date

Database

Initial
Hits

Articles
Excluded

Total
Selected for
Review

Lymphedema and
early intervention

10/10/17
4:17pm

PubMed

87

65

22

Lymphedema and
early intervention

10/22/17
6:25pm

CINAHL

26

22
(2 duplicates)

4

Lymphedema and
early intervention

11/03/17
6:57pm

MedLine
(EBSCO)

43

41
(16 duplicates)

2

Lymphedema and
early intervention

11/14/17
9:28am

Health Source:
Nursing/Acade
mic Ed
(EBSCO)

6

6
(4 duplicates)

0

Lymphedema and
early intervention

11/14/17
9:37am

PEDro

5

5
(4 duplicates)

0

Lymphedema AND
intervention AND
early AND oncology

11/4/17
9:41am

PubMed

317

315
(12 duplicates)

2

Lymphedema and
early intervention

01/19/18
3:15pm

PubMed

90

89
(87 duplicates)

1

Total number of articles used in review from database searches = 31
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Table 2. Articles from citation tracking.
Article

Date

Database

Initial Hits

Articles
Excluded

Total
Selected for
Review

*n/a as of 11/14/17
In progress
Total number of articles used in review from citation tracking = 0

Table 3. Articles from reference tracking.
Article

Stout, N. L., Binkley, J.
M., Schmitz, K. H.,
Andrews, K., Hayes,
S.C., Campbell, K. L.,
...Smith, R. A. (2012). A
prospective surveillance
model for rehabilitation
for women with breast
cancer. Cancer, 118,
2191-2200.
doi:10.1002/cncr.27476

Date

Articles Referenced

Articles
Excluded

Total Selected
for Review

11/04/17

119

117

2

87

86

1

Fu, M. R., Deng, J., &
Armer, J. M. (2014).
01/18/19
Putting evidence into
practice: Cancer-related
lymphedema. Clinical
Journal of Oncology
Nursing, 18, 68-79.
doi:10.1188/14.cjon.s3.68
-79

Total number of articles used in review from reference tracking = 3
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Table 3. Articles from chair recommendations.
Article

Date

Total Selected
for Review

Maher, C., & Mendonca, R. J.
(2018). Impact of an activitybased program on health, quality
of life, and occupational
performance of women
diagnosed with cancer. AJOT,
72.
doi: 10.5014/ajot.2018.023663

3/1/2018

1

Total number of articles used in review from chair
recommendations = 1
Total number of articles used in review from database searches = 31
Total number of articles used in review from citation tracking = 0
Total number of articles used in review from reference tracking = 3
Total number of articles used in review from UPS Master’s Thesis = 0
Total number of articles used in review from chair recommendations = 1
Total number of articles used in CAT = 35

Summary of Study Designs of Articles Selected for the CAT Table
Pyramid
Side

Study Design/Methodology of Selected
Articles

Number of
Articles
Selected

Experimental

3 Meta-Analyses of Experimental Trials
5 Individual Randomized Controlled Trials
1 Controlled Clinical Trials
0 Single Subject Studies

9

Outcome

0 Meta-Analyses of Related Outcome Studies
0 Individual Quasi-Experimental Studies
3 Case-Control Studies
7 One Group Pre-Post Studies

10
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Qualitative

___Meta-Syntheses of Related Qualitative
Studies
___Small Group Qualitative Studies
___brief vs prolonged engagement with
participants
___triangulation of data (multiple sources)
___interpretation (peer & member-checking)
___a posteriori (exploratory) vs a priori
(confirmatory) interpretive scheme
___Qualitative Study on a Single Person

0

Descriptive

1 Systematic Reviews of Related Descriptive
Studies
4 Association, Correlational Studies
1 Multiple Case Studies (Series), Normative
Studies
0 Individual Case Studies

6

Comments: 10 articles were not classifiable on the pyramid because
of the nature of the studies (cost analyses, literature reviews and
prospective models).

AOTA Levels
I- 9
II- 5
III- 7
IV- 4
V- 10

TOTAL =
25 + 10 =
35
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Table Summarizing QUANTITATIVE Articles
Quantitative Articles
Author
Year
Journal
Country

Study
Objectives

Study
Design/
Level of
Evidence

Participants

Interventions &
Outcome
Measures

Summary of
Results

Study
Limitations

RCT, single
blinded
Level I
E2
Pedro: 8/10

N= 116 females
TG= 59
CG= 57

Tx= 3 weeks, 3x/week.
Tx carried out by one
physiotherapist

TG had 4 cases of 2˚
LY
CG had 14 cases of
2˚ LY (p < .05)

Duration of follow-up
is only one year post
surgery

I= ALND, recruited
between May 2005
& June 2007

TG : Education, MLD,
scar massage, stretching
& shoulder exercises

E= w/out ALND,
w/bilateral BC,
systemic disease,
locoregional
recurrence or those
w/contraindications
to physiotherapy

CG : Education only

Outcome: Limb Volume Change
Torres Lacomba
et al.,
2010,
BMJ,

To determine the
effectiveness of
early
physiotherapy in
↓ risk of 2˚ LY
post BC surgery

O= Follow-up
measurements @ 4
weeks, 3, 6, & 12
months post surgery

@ 12-month followup, CG arm volume
in affected arm was
on average 5.1% >
unaffected arm. TG
volume of affected
arm was only 1.6% >
unaffected arm (p <
.05)

Incidence of 2˚ LY (≥
2cm ↑ in CM) measured
by blinded therapist

2˚ LY developed 4x
faster in CG
compared to TG

Tx= 4-12 weeks postsurgery
TG: RESTORE
program w/LY
prevention module,
delivered by LY
specialist (OT or PT).
Included instruction &

Risk factors between
groups were similar,
BMI was > in TG
82 patients completed
RESTORE program
(TG=43, CG=39)
28% were classified
as obese
Mean arm volume
change @ 18 months
was 33.5ml for TG,

Spain

Anderson et al.,
2012,
Jnl Cancer
Surviv,
US

To determine the
effect of an
exercise program
on QOL, physical
function & arm
volume in nonmetastatic BC

RCT, single
blind study
Level I
E2
Pedro: 7/10

N= 104 adult
females, 32-82
years
TG= 52
CG=52
I= Dx of stage 1-3
BC w/ALND or
SLND, no previous

Recruited patients from
only one hospital
Chose a specific dx
criterion, other criterion
methods may have
resulted in more/fewer
cases of LY
No demographic info
about patients

Used a combination of
tx: strength training,
compression, LY
prevention exercises
Those in TG had >
contact w/health care
providers
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history of BC, ≥ 18
years of age, living
w/in 30 miles of
study site, able to
participate in
moderate exercise
program
E= Homebound,
exercise
contraindicated,
dependent upon
walker or
wheelchair for
mobility, Dx
dementia, peripheral
artery disease,
unstable angina,
cardiac
disturbances,
chronic disease

Box et al.,
2002,
Breast Cancer
Res & Treat,
AUS

To examine the
effects of early
intervention on
progression &
severity in
patients w/BCRL

RCT
Level I
E2
Pedro: 6/10

N= 65 females
Mean age = 56.06
years
I= ALND or
modified radical
mastectomy
between July 1st
1996 to June 30th
1997

care for limb,
awareness of LY, 1
month follow-up. Given
compression garment, 2
exercise sessions per
week (5 min warmup,
30 min aerobic, 20 min
U&L body, 10 min
stretching) for 3
months. Months 4-6
could be home based &
1x/week, months 7-12
no exercise required

13

& 60.4ml in CG (p <
.05)
QOL scores were not
statistically different
between groups (p >
.05)

Larger standard error in
arm volume
measurements, made
difference between
groups not statistically
significant

Provides evidence for
benefit & safety of
exercise programs &
do not ↑risk of LY

22 patients dropped out
(TG=9, CG=13)

TG had an incidence
rate of 11% for 2˚
LY, while CG had an
incidence rate of 30%

Size of TG & CG were
not given

CG: Given info about
LY, prevention
exercises, quarterly
newsletter about diet &
nutrition
O= Limb volume via
VD assessed @
baseline, 3, 6, 9, 12 &
18 months post-surgery.
Health related QOL
assessed w/Functional
Assessment of Cancer
Therapy-Breast Cancer
at baseline 15 months
Tx=
TG: Physiotherapy
management care plan
CG: Tx condition was
not specified
O= CM & VD.
Measures were taken
pre-op, 5th day post-op,
1, 3, 6, 12 and 24

Patient arm volume
still ↑ despite tx
Trend for ↑ risk for
LY w/a > BMI

Details of the
physiotherapy
management plan &
CG tx were not
provided
Settings of txs & length
of tx were not given
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Oliveria et al.,
2014,
Physiotherapy
Theory &
Practice,

To compare MLD
& active exercise
on post-op
complications in
women w/BC

Nonrandomized
controlled
clinical trial
Level II
E3
Pedro: 5/10

E= Confused mental
state, reconstructive
surgery, lived
beyond 50km from
hospital, refused
random allocation,
unable to obtain
informed consent &
pre-data
N= 89 females
Exercise group= 46
MLD group= 43
I= Unilateral BC
w/ALND between
October 2006 &
July 2011

Brazil
E= Immediate
breast
reconstruction,
difference in UE
CM > 2cm presurgery, motor
deficit or infection
in UE & pre-op
radiotherapy

Akita et al.,
2017,
Jnl Amer Soc
Plastic Surg,

To investigate
early changes in
LY using
indocyanine green
lymphography &
propose a new

Prospective
cohort study
Level III
O4
Pedro: 3/6

N= 190 females
I= consecutive 1˚
BC patients who
underwent surgery,
included SLND or

14

months post-op by a
blinded physiotherapist

Tx=
Exercise group: Given
educational strategy &
40-minute group
exercise sessions
2x/week for 30 days. 19
exercises were
performed under
supervision of physical
therapist
MLD group: Given
educational strategy &
40-minute individual
MLD 2x/week for 30
days performed by 3
experienced physical
therapists
O= CM (↑ by 2cm or
more = LY
development), Shoulder
ROM measurements
taken pre-op & 60 days
post-surgery
Tx= Injection of
indocyanine green
subcutaneously into
affected UE. One hour
post injection,
circumferential

There was no
significant difference
between shoulder
ROM & CM pre-op
& post-op
measurements
between groups

No blinding of
participants or
therapists
Type of ROM was not
specified

Exercise is not
contraindicated in
patients at risk for
developing LY

35 patients needed
compression therapy,
11 of those patients
improved while 24
needed persistent
compression therapy

Out of 390 patients,
only 190 were followed
up for a full year
Mean follow-up was
short (20 months)
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Japan

strategy for early
Dx & tx of BCRL

ALND from July
2013 to July 2014
E= Iodine allergy,
pregnancy,
recurrence
following previous
BC, & psychiatric
disorders

fluorescent images of
lymphatic drainage
channels obtained.
Images classified into
patterns: linear, splash,
stardust, diffuse or no
flow
L-Dex value ↑ of 10%
or > is a significant
limb volume ↑
Those w/splash pattern
followed w/no tx.
Stardust, diffuse or no
flow received skin care,
exercise, elevation and
compression sleeve.
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This method of
measurement can be
applied to bilateral
cases, low cost, less
cumbersome

resulting in a net
incidence rate that
could not be fixed

Detected lymphatic
dysfunction in 21 out
of 35 patients before
any limb volume
change was visible
Risk factors found
were age, BMI,
radiation therapy,
ALND & docetaxel

O= Changes in limb
volume

Jang et al.,
2015,
PLOS One,

To evaluate the
effects of arm
swelling duration
on shoulder
pathology in
patients w/BCRL

Crosssectional
study
Level IV
D2
Pedro: 2/3

N= 47 women
I= Unilateral LY,
Dx w/BCRL & free
of cancer at time of
study

Korea
E= Bilateral LY,
lymphangitis, skin
disease,
inflammatory
shoulder arthritis,
previous shoulder

Measurements taken
pre-op & follow-up
measurements 1, 3, &
every 3 months
thereafter until 12
months post-surgery
Tx= Patients underwent
musculoskeletal
examination &
ultrasound of shoulder
region & shoulder
ROM. All were done by
a certified Korean
physiatrist, then
confirmed by a second
physiatrist
Arm measurements
were also taken

41/47 (87.2%) of
patients were found
to have shoulder
abnormalities
Those w/
supraspinatus tendon
tear were found to
have a significantly
longer duration of LY
(p < .05)

Participants were taken
from one hospital
Degenerative cause of
shoulder pathology
could have not been
related to LY
Duration of LY was
determined by patient’s
self-report of
symptoms. It is unclear
when LY was Dx
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trauma, or previous
shoulder surgery
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O= CM, comparison of
duration of LY
according to shoulder
pathology

The pathology of
shoulder pain is
related to the duration
of LY. Duration of
LY influences the
pathology, but is not
correlated with
symptoms

Tx= 4-6 weeks post-op,
for 8 weeks
TG : Seen weekly,
participated in
resistance training,
passive stretching &
given home program. 3
stretches to perform
daily, hold for 5-15
min. Resistance
training = 2 sets, 8-15
reps of each exercise (#
of exercises not given)

Changes in symptoms
from self-report QOL
survey were not
significant between
groups

Type of ROM
measurements were not
provided

Outcome: ROM, Strength & Limb Volume Change
Kilbreath et al.,
2012,
Breast Cancer
Res & Treat,
AUS

To determine
whether an
exercise program
reduces upper
limb impairments
in women treated
for early BC

RCT, double
blinded
Level I
E2
Pedro: 9/10

N= 160 female
participants, 24-82
years
TG:
ALND= 50
SLND= 31
CG:
ALND= 46
SLND= 33
I= Undergone
surgery for stage 13 BC, either SLND
or ALND, could
communicate in
English, attend tx &
follow-up visits
E= History of LY,
bilateral BC,
metastatic BC, preexisting arm
impairments

CG : No exercises
given, education only.
Assessed fortnighlty for
LY. If LY, tx was
compression garment
All women received
post op care including :
literature about
prevention, seen by
breast nurse or
physiotherapist or OT,
patients given info
about post-op exercises
O= Pre/post tx & 6
month follow-up

Shoulder ROM in
affected arm
increased
significantly for TG
compared to CG
immediately post
intervention (for
abduction & flexion,
p < .05)
Shoulder strength
increased
significantly in TG
compared to CG
immediately post
intervention (for
abductors & flexors,
p < .05)
No significant
changes in LY
occurred in either
group (p > .05)

1˚ outcome measure
relies on self-report
CG likely exposed to
exercise
recommendations
during post-op hospital
stay
No follow-up before 6
months
Participants were
younger on average
than women Dx w/BC
Type of ROM
measurements were not
specified
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Ammitzboll et al.,
2017,
ACTA
Oncologica,
Denmark

To determine if
progressive
strength training
is feasible & safe
for one year post
BC to inform
future RCT

Prospective
pilot trial
Level III
O4
Pedro: 3/6

N= 8 female BC
patients recruited
August 2015
I= between ages 1875, ALND for 1˚
unilateral BC,
transportation to
hospital, &
physically/mentally
able to participate in
exercise
E= previous ALND
(either side), 1˚
breast
reconstruction,
metastatic disease,
& history of LY

measurements taken by
blinded researcher.
Self-report QOL
survey, shoulder ROM,
shoulder muscle
strength, CM
Tx= Individualized
exercise programs
based on 7 rep max.
Took place in
Physiotheraphy Dept @
Herlev hospital &
supervised by
physiotherapists.
Regime had 5 modules,
each being 4 weeks in
duration. 6 exercises, 3
sets per module.
Exercised 2x @
hospital, 1x @ clients
choice per wk. After 20
weeks, patient
exercised on their own
Symptoms recorded
weekly. Arm volume
@ 12 & 20 weeks.
Symptoms lasting 2+
weeks, extra arm
measurements taken.
BMI @ baseline,
dynamic strength @
baseline, 12, 20 & 50
weeks, isometric
strength @ baseline, 20
& 50 weeks, hand
strength & shoulder
PROM @ baseline &
50 weeks, questionnaire
@ baseline, 20 & 50
weeks
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1 patient had 5% ↑ in
interlimb volume
difference @ 50 week
follow-up. 3 had ↑
interlimb volume
difference &
symptoms during
program, but @ 50
week follow-up,
returned to baseline
Dynamic/isometric
muscle strength: all
showed ↑ @ 50 week
follow-up
Grip strength: ↓
bilaterally @ 50 week
follow-up
Shoulder PROM:
Shoulder abd seemed
most restricted postsurgery
Exercise program
was found to be
feasible & had high
satisfaction,
adherence was
moderate. Muscle
strength gains were
greatest during
supervised sessions

Drop-out rate of 25%
(n=2)
Focused only on one
component of rehab
(strength)
Small sample size

EMERGING OPPORTUNITIES: LYMPHEDEMA

Springer et al.,
2010,
Breast Cancer
Res & Treat,

To examine the
extent & time
course of UE
impairment &
dysfunction in
women being
treated for BC

Prospective
observational
study
Level III
O4
Pedro: 3/6

US

N= 94 participants
I= Women dx
w/unilateral stage 13 BC between 2001
and 2006
E= Male, < 18 years
of age, history of
BC, bilateral BC,
injury/surgery
affected UE

O= feasibility
outcomes, VD, BMI,
Dynamic muscle
strength, isometric
muscle strength, hand
grip strength &
shoulder PROM,
questionnaire data
Tx= Evaluated by
physical therapist at
baseline & follow-up
appointment
Instructed on post-op
AROM exercise
program & education
on LY. If patient Dx
w/LY, tx was initiated.
No movement
restrictions were given
O= Measurements
taken pre-op, 1, 3-6
months post-op & 12
months+ post-op
Shoulder AROM
(flexion, abduction,
internal rotation,
external rotation),
manual muscle testing,
UE volume

Stout Gergich et
al.,
2008,
Cancer,
US

To investigate the
efficacy of a
surveillance
method for early
Dx & tx of
subclinical LY

Case control,
observational
study
Level II
O3
Pedro: 4/6

N= 196 patients
TG= 43
w/subclinical LY
(volume ↑ > 3%),
aged 34-82 years
CG= 43 w/out LY,
aged 33-81 years

Tx= Upon Dx of LY,
patient given
compression garment to
wear daily for 4 weeks.
No activity limitations
were given
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Shoulder AROM &
strength ↑ after 1
month post-op

All subjects from a
military
background/association

@ 12 months, 92%
reported no or slight
limitations
performing hard UE
functional tasks

Mean age was younger
than most studies

Limb volume ↑ over
course of follow-up,
however differences
between the affected
& unaffected limbs
was insignificant,
thought to be due to
weight gain
Significant difference
found between those
w/subclinical LY &
those w/out (p < .05)
Mean ↑ of volume
change in TG was 83
mL and 2.7 mL in
CG
TG had > UE volume
than CG @ beginning
of intervention

Many sought out after
care closer to home,
resulting in less patients
@ follow-up & varying
tx from other clinics

Perometer used to Dx
LY may not be
financially available
Unable to control BC
related side effects
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I= Newly Dx
w/unilateral early
stage BC

O= Bilateral AROM,
strength & UE volume
were assessed pre-op, 1,
3, 6, 9, 12 & 18 months
post-op

E= History of BC,
bilateral BC, prior
trauma/surgery on
UE
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Follow-up after
intervention, limb
volume ↓ was 46 mL
w/activity related
garment wear,
compared to 2.3 mL
↓ in CG

Setting of tx not
indicated
Tx for CG was not
specified

Outcome: QOL
Thakur et al.,
2016,
Indian Jrnl of
Physiotherapy &
OT,

To determine
effectiveness of
early
physiotherapy to
reduce risk of
developing 2˚ LY

RCT
Level I
E2
Pedro: 5/10

I= Above age 18,
unilateral BC
surgery w/ALND

India

Gordon et al.,
2005,
Breast Canc Res
& Treat,
AUS

N= 20 females
TG= 10
CG= 10

E=
Recurrence/relapse
of BC, bilateral BC,
untreated infection,
heart disease, renal
disease, deep vein
thrombosis, & any
other
physiotherapeutic
contraindications
To assess changes
in health related
QOL & upper
body disability
over time

Longitudinal
Quasiexperimental
design
Level II
O3
Pedro: 4/6

N= 275 women
TG: DAART
program = 36
STRETCH program
= 31
CG = 208
I= 1˚ unilateral BC,
spoke English, &
were between 25-74

Tx=
TG: Given educational
strategy & early
physiotherapy
intervention (MLD, UE
stretching exercises,
active/active assisted
shoulder exercises,
proprioceptive
neuromuscular
facilitation exercises)
CG: Given only
educational strategy
Both programs lasted 3
weeks w/3 visits per
week
O= QOL & VD
Tx=
TG: DAART (homebased physiotherapy) or
STRETCH (groupbased & psychosocial
tx) program. The goal
of the programs was to
↑ UE strength &
provide support

Mean QOL scores
were significantly
better for the TG than
the CG (p < .05)
Mean VD
measurements were
significantly > for
CG post-tx (p < .05)

Small sample size
Details regarding
educational materials
were not provided
Information about what
QOL survey used was
not given

Intervention w/early
physiotherapy &
education was
significantly more
effective @ reducing
risk for developing 2˚
LY compared to just
education

Very brief results
section, only given
tables w/no explanation

DAART participants
showed clinically
significant
improvements in UE
function & health
related QOL

CG was only available
for measures taken at 6
& 12 months

There was minimal
change in QOL & UE

No blinding of subjects
or assessors

Selection bias of TG
because they were
generally healthier than
others w/BC, maybe
impacting
generalizability
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Maher &
Mendonca,
2018,
AJOT,
USA

To determine
impact of a 1week activity
program on
health, QOL &
occupational
performance in
women Dx
w/cancer.

One-group
Pre-Post test
Level III
O4
Pedro: 3/6
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w/no cognitive
impairments

CG: Did not receive
support group tx

function in
STRETCH group

E= Too ill, did not
understand English,
or previously
attended one of the
intervention
programs

O= Health related QOL
& UE strength.
Measures were taken at
pre/post tx, 6 & 12
months from Dx

Early intervention
may expedite
recovery & enhance
QOL

Between May 2002
& July 2003
N= 71 females Dx
w/cancer
I= Women
w/cancer, aged 21
or older, &
clearance from
physician
E= Not specified

Only relevant to those
w/unilateral BC
Very little information
was given about what
the TG & CG were
given as tx
Groups were not similar
at baseline

Tx= 5 day long activity
camp from 9 am to 1pm
addressing QOL,
health, well-being and
occupational
performance. 4 classes
were done each day and
included activities such
as Tai Chi, dance,
poetry, scrapbooking,
meditation, yoga,
gardening, cooking, and
nutrition. Classes were
taught by occupational
therapists and
occupational therapy
students
O= 3 assessments were
administered: 36 item
Short Form Health
Survey, World Health
Organization QOL
Brief Survey, and the
COPM. COPM was
administered on day 1,
5 and @ 6 week follow
up. QOL and health

A significant
difference was found
on the QOL Social
Relationships
subscale (p = .002,
w/moderate effect
size, dz = 0.37). No
other subscales had
significant differences
@ posttest
Mental Health subscale
on the health survey did
have a moderate effect
size, but was not
significantly different
(dz = 0.28)
Results of COPM were
statistically significant
between pre-posttest,
pre & follow up, & post
to follow up (p < .05)
implying improved
occupational
functioning

Women who had
completed and were
actively completing
cancer tx were used in
the study. 6 recruits
were lost due to
medical complications
from tx
All 3 assessments were
time consuming surveys
Exclusion criteria were
not specified
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O’Toole et al.,
2015,
Breast Cancer
Res & Treat,

To assess the
association
between BCRL &
ability to perform
ADLs

Prospective
surveillance
Level IV
D2
Pedro: 2/3

N= 324 females
between 2005 &
2014. Median age@
Dx = 56 years
I= Unilateral BC

US

E= Bilateral breast
surgery &
metastatic cancer

survey were
administered on day 1
and @ 6 week follow
up.
Tx= Pre-op limb
volume measurement
w/perometry.
Perometry
measurements post-op,
after chemo/radiation,
& every 3-7 months @
each visit, questionnaire
for QOL
O= RVC (BCRL
defined as RVC↑ ≥
10%)
QOL survey scores
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32% had one or more
RVC ↑ between 510%
8% had RVC ↑ ≥
10% post-op.
No significant
association between
BCRL & ability to
perform ADLs

↓ rate of LY in this
cohort
Their program utilizes
early intervention
strategies, which can
slow LY progression.
More severe LY may
result in > impact on
function

Significant
association between
physical function,
pain & fear w/ability
to perform ADLs. ↓
functional scores
were associated w/ ↑
fear, > pain,
mastectomy &
ALND (p < .05)

Outcome: Risk Factors & Limb Volume Change
Kaufman et al.,
2017,
Breast Cancer
Res & Treat,
US

To assess impact
of early
intervention using
BIS as
surveillance tool
to detect BCRL

Prospective
BCRL
surveillance
program
Level III
O4
Pedro: 4/6

N= 206 BC patients,
mean age of 61.
Between August
2010 & December
2016
High risk patients =
ALND & regional
node irradiation
patients
I= patients w/BC,
undergoing BC
surgery

Tx= pre-op baseline LDex measures, post-op
measures @ 6 weeks, &
3-6 month intervals.
Subclinical BCRL
defined as : L-Dex
score ↑ > 10 from
baseline. If > 10, patient
given over the counter
compression garment
for 4 weeks. Patients
underwent repeated LDex measures, if no
resolution, patients

Overall, 9.8% of
patients (n=21) were
Dx w/subclinical
BCRL. 7 of these
were ALND patients
& 12 were SLND
patients
Findings supported
use of structured
surveillance
programs to ↓
morbidity of BCRL

Follow-up time was
short (25 months),
limiting long-term
outcomes
No control group for
comparison if LY
would have resolved
w/out tx
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E= no implantable
devices
(pacemakers),
pregnancy, renal
failure, & heart
failure

Jammallo et al.,
2013,
Breast Cancer
Res Treat,

To assess the
impact of pre-op
BMI & post-op
weight change on
risk for LY

Pre-Post study
Level III
O4
Pedro: 3/6

N= 787 females
Between 2005 &
2011
I= Undergoing tx
for 1˚ BC at their
institution

US
E= Bilateral breast
surgery &
metastatic disease

Soyder et al.,
2014,
Jnl Breast Health,
Turkey

To determine
post-op LY
frequency &
identify risk
factors

Retrospective
study
Level IV
D2
Pedro: 2/3

N= 101 females Dx
w/unilateral BC
I= surgery to breast
& axilla between
January 2010 March 2011
E= Were not
specified

were defined as chronic
BCRL & sent to CDT
O= L-Dex
measurements
Client characteristics :
BMI, age.
Tx characteristics :
surgery, axillary
management, chemo,
radiation, & regional
node irradiation
Tx= Pre-op BMI & arm
volume w/perometry
was taken. LY was
defined as RVC ↑ ≥
10%, occurring > 3
months post-op
Post-op BMI & arm
volume w/perometry
taken
O= BMI & arm
volume, evaluated
every 3-8 months postop (depended on clients
next visit)
Tx : CM 12th months
follow-up post surgery.
If LY present, patient
referred to LY tx center.
Patient characteristics
were taken
O= CM
Risk factors : Age,
BMI, smoking status,
arm dominance
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Found ALND &
regional node
irradiation were risk
factors for developing
subclinical BCRL
w/elevated BMI.

Participants w/BMI ≥
30 had 4.5x ↑ risk for
developing LY
compared to BMI <
25 (p < .05)
ALND & regional
lymph node radiation
were found to be risk
factors for LY (p <
.05)

LY was found in 7
patients @ 12 months
assessment
No risk factors were
found to be
significantly
correlated w/LY
development (p >
.05), but 6 cases had
a BMI > 25

Authors claim LY was
measured by perometry,
but no data was given
to show those
measurements, only
reported BMI
BMI & perometry
measurements were not
taken during same visit
Non-standardized
measurement schedule
was used (every 3-8
months depending on
clients visit)
No pre-op
measurements
Exclusion criteria were
not specified
Details of tx were not
provided
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Applied tx factors :
surgery type, dissected
# lymph node, lymph
node positivity, post-op
seroma & infection,
chemo or radiation,
grade of tumor, size of
tumor
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Applied tx factors
that were
significantly
correlated w/LY
were: axillary
dissection or SLND,
lymph node
positivity, > 15
lymph node
dissections, radiation
therapy & tumor size
(p < .05)
Radiation therapy &
axillary dissection
appear to be major
factors that ↑ risk for
LY

Outcome: Prospective Surveillance Model & Cost
Whitworth &
Cooper,
2017,
Breast Jrnl,
US

To evaluate
patient outcomes
of a large group
using prospective
surveillance &
BIS

Prospective
Surveillance
Level III
Pyramid: O4
Pedro: 3/6

N= 596 women at
risk for developing
BCRL.
I= Nashville Breast
Center, between
April 2010 &
November 2016.
E= were not
specified.

Tx= Patients followed
prospectively using a
standard protocol
including BCRL
education & pre/post
BIS measurements. If
L-Dex measurements ↑
> 10 points from
baseline (subclinical
LY), patient given over
the counter
compression garment
for 4 weeks, then LDex score was
rechecked. Median
follow-up time was 17
months, w/an average
of 4 visits.
Patients were
considered high risk if

Overall, 73 patients
had abnormal L-Dex
levels. 18 of these
patients scores did
not return to normal
and required CDT.
Patients undergoing
ALND were more
likely to develop an
abnormal L-Dex
score & unresolved
BCRL (p < .05).
This evidence
supports the use of
prospective
surveillance for at
risk patients using
BIS to detect
subclinical LY.

No exclusion criteria
were provided.
Did not provide
information on when
follow-up visits
occurred after surgery.
Little information was
given about the
standard protocol used,
education provided &
how/where
measurements were
taken.
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Shih et al.,
2009,

To examine the
economic burden,
incidence & risk
factors of BCRL

Jrnl of Clinical
Oncol,

Regression
Analysis
Level II
Pyramid: D2
Pedro: 2/3

N= 1,877 women
W/BCRL: n= 180
W/out BCRL: n=
1,697.
I= Women, been
observed by
physician for 2
years, & ICD-9
codes 457.0 &
457.1 between 1997
& 2003.

US

BMI > 25 (n= 379),
ALND (n= 93),
regional nodal
irradiation (n= 17) or
taxane chemotherapy
(n= 163).
Tx= Matched CG was
created to compare
costs & complications
of BCRL.
Multivariate logistic
regression was
performed to ascertain
factors associated
w/BCRL & to compare
the rates of
complications between
groups.

E= Men, enrollees
w/missing
identifiers, & <27
months of
continuous care.
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10% (n= 180) women
had Dx of LY w/in 2
years of BC tx.
Significantly higher
proportion of women
w/BCRL underwent
mastectomy, ALND,
chemotherapy or
lived in the West (p <
.05).
Incidence of BCRL ↑
from 9.6% in 2 year
follow up to 12% in 4
year follow up.
15.9% of women
w/BCRL developed
lymphangitis &
14.1% developed
cellulitis, compared
to 8.4% & 7.8% in
CG.

Cost of BCRL was
likely underestimated
because costs were
estimated at first 2
years of BC tx, not 2
years after LY Dx.
ICD-9 codes in claims
data were used to
identify women. Some
women in CG may of
had LY, but Dx was not
added to insurance
claims.
Participants were
working-age women
w/BCRL and therefor
may not be
generalizable to elderly
women w/BCRL.

Total cost for tx in
BCRL group was
$86,707 & &64,554
for the CG.

Stout et al.,
2012,

To compare a
prospective model
w/a traditional

Perspective
article on cost
analysis

I= were not
specified

Tx= Prospective model
or traditional model

The cost of treating &
managing BCRL in
one patient

Does not consider
indirect costs
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Physical Therapy,

model & examine
direct tx costs for
each program

Level V
Pyramid N/A
Pedro: N/A

E= were not
specified

US

Methods for
determining costs:
Average retail costs
considered for durable
medical equipment,
incidence data used to
approximately newly
Dx cases, only direct tx
costs associated
w/intervention were
included. Defined direct
tx costs, early-stage
LY, & advanced-stage
LY
O= costs of prospective
model & costs of
traditional model
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w/prospective model
per year for earlystage LY is $636.19
Cost of treating &
managing advancedstage LY
w/traditional model
would be $3,124.92
For 100 patients,
prospective model
costs range from
$29,315.50 to
$43,799.20 per year.
Traditional model
costs range from
$32,811.66 to
$149,996.16 per year
per 100 patients

Need to consider
additional cost sensitive
variables like time lost
from work, ADLs,
QOL & disability
Estimated costs based
on estimated incidence
rates
Assumed LY in patients
in prospective model
did not progress
Only considered costs
of tx for single BC
related impairments,
not bilateral

Prospective
surveillance is
effective for early
detection & tx. May ↓
overall health care
costs compared to
traditional model

Carlson, R.,
2012,
Oncol Times,
US

To examine the
evidence for
implementing the
prospective
surveillance
model into
standard care

Opinion
Level V
Pyramid N/A
Pedro: N/A

N/A

Tx= Stout et al. (2012,
next table entry)
prospective surveillance
model
O= Should prospective
surveillance model be
implemented

Upfront cost for
prospective model
may be a barrier to
implementation
No consensus has
been reached. The
prospective model
has positives &
negatives to it,
however there does
need to be a more
standardized form of

No resources or
references cited to back
up authors opinions
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Stout et al.,
2012,
Cancer,

To introduce a
prospective
surveillance
model of care for
BC physical
rehabilitation

Prospective
surveillance
model
Level V
Pyramid N/A
Pedro: N/A

I & E= Would be
based on a risk &
impairment
screening to
determine if eligible
for tx

Tx= Pre-op eval &
education
Early post-op rehab: reeval & exercise
program

US
Ongoing surveillance
O= feasibility of such a
program
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care for patients
w/BCRL
There is a need for
ongoing surveillance
for those @ risk for
LY
Prospective
surveillance model
provides framework
for values survivors
indicate as important

Little info provided on
cost of prospective
surveillance model
No inclusion &
exclusion criteria for
prospective patients

Outcome: UE Function
Singh et al.,
2013,
Physiotherapy,
Canada

To compare the
effects of arm
morbidity w/early
physiotherapy
intervention to an
intervention
w/pre-op
education only

Prospective
quasiexperimental
prettestposttest
Level II
O3
Pedro: 4/6

N= 72 females
TG= 41
CG= 31
I= Women
receiving surgery
for BC including
modified radical
mastectomy, simple
mastectomy or
breast conserving
surgery. All stages
of cancer were
included
E= Transverse
rectus abdominis
myocutaneous flap
surgery at time of
breast surgery,
could not provide
informed consent in
English, or unable
to physically engage
in physiotherapy

Tx=
TG: Received
standardized pre-op
education & seen twice
post-op (1 & 6 months).
Further tx were
provided if needed (↓
AROM, ↓ in strength, ↑
in limb girth, or poor
posture). Focus was on
self-management
techniques
(compression), scar
tissue massage, &
progressive shoulder
exercises
CG: Received
standardized pre-op
education only
All education & followup visits were done by
one of two trained
physiotherapists

For the TG, shoulder
AROM had returned
close to baseline,
while the CG post-op
measurements were
lower than their
baseline

Duration of tx sessions
were not given

At post-op,
differences in QOL
were not statistically
significant in TG vs
CG (p > .05)

Physiotherapists
performing follow-up
measures were not
blinded

There was a lower
incidence of LY in
TG than CG, but it
was not statistically
significant (p = 0.19)
Arm morbidity was
lower in the TG than
the CG but was also
not statistically
significant

Longer follow-up may
be needed to identify
the true incidence of
arm morbidity
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O= Composite measure
of arm morbidity (↓ in
shoulder AROM ≥ 10˚)
Presence of LY (2cm ↑
in UE circumference
compared to pre-op).
self-report
questionnaires (UE
function & QOL)

Schmitz et al.,
2012,
Cancer,
AUS

To provide data
for the prevalence
of adverse effects
in BC survivors in
a 6-year followup

Longitudinal
observational
cohort study
Level IV
D3
Pedro: 1/3

N= 287 women
I= Unilateral BC, 75
or younger, 100km
radius of Brisbane,
between January &
December 2002
E= Were not
specified

Measurements collected
pre-op (baseline) & 7
months post-op for all
participants. TG was
assessed at 1 & 6
months post-op
(additional sessions
were recorded)
Tx= Personal, tumor &
treatment characteristics
were collected by
questionnaires.
Functional Assessment
of Cancer Therapy
Breast +4 & the
Disability of the Arm,
Shoulder & Hand were
given to the clients
O= UE function &
symptoms. Surveys &
characteristics were
measured at baseline, 6,
12, 18 months & 6
years follow-up.
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There needs to be
more effective
management to treat
& identify UE
impairments in those
w/BC

At 6-year follow-up,
60% of women were
experiencing more
than 1 adverse tx
effect
Prevalence of most
physical impairments
decreased throughout
the 6 years follow-up,
except for LY &
weight gain
These findings lend
merit to the proposal
of a prospective
surveillance for
adverse tx effects

Did not specify
exclusion criteria
Relied on patient recall
& report of physical
limitations
It is hard to determine if
some of the adverse
effects were caused by
BC tx
Comorbid conditions &
natural aging process
need to be considered
Adverse effects were
limited to those that
were established &
clinically defined
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High attrition, only 80
patients completed all
measures at all time
points

Abbreviation Key for Quantitative Table
ALND = axillary lymph node biopsy, A/PROM = active/passive range of motion, BC = breast cancer, BCRL = breast cancer related lymphedema, BIS =
bioimpedance spectroscopy, BMI = body mass index, CDT = complete decongestive therapy, CG = control group, CM = circumferential measure, Dx =
diagnosis/diagnostic, E = exclusion, I = inclusion, L-Dex = lymphedema index, LY = lymphedema, O = outcomes, QOL = quality of life, RVC = relative volume
change, SLND = sentinel lymph node biopsy, TG = treatment group, Tx = treatment, UE = upper extremity, VD = volume displacement

Table Summarizing Meta-Analyses/Meta-Syntheses/Systematic Review Articles
Systematic Reviews/Meta-Analyses/Meta-Syntheses
Author
Year
Journal
Country

Study
Objectives

Study
Design/
Level of
Evidence

Number of Papers Included,
Inclusion and Exclusion Criteria

Interventions &
Outcome
Measures

Summary of
Results

Study
Limitations

N/A

O= Ways to
improve QOL for
BCRL patient
Recent information
regarding Dx, tx,
risk factors

Dx measures: VD,
CM, perometry &
BIS
Risk factors:
regional lymph
node radiation,
method of surgery,
high BMI, weight
fluctuations,
subclinical edema
& cellulitis

Suggested the need
to improve QOL for
survivors, however
did not recommend
any ways to do that

Non-Systematic Reviews
Outcome : QOL, Dx & Tx Trends
Sayegh et
al.,
2017,
Curr Breast
Cancer Rep,
US

To discuss recent
studies regarding
risk factors, Dx,
prevention
through early
screening &
intervention of
BCRL to improve
QOL for
survivors

Nonsystematic
Review
Level V
N/A

Txs: regular
screening using
various methods
(VD, CM,
perometry, BIS),

Out of 94
references, only
provided basic
background
information on 7 of
them
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CDT, MLD,
intermittent
pneumatic
compression,
compression
garments, exercise,
skincare, education
& self-management

Passik &
McDonald,
1998,
Cancer,
US

To identify &
discuss the
psychosocial
impacts of LY

Nonsystematic
Review
Level V
N/A

N/A

O= Psychological &
functional
morbidity,
predictors of
psychological &
functional
morbidity, as well as
intervention &
prevention of LY

Screening may
have financial
benefits, cost per
year to tx early
stage BCRL =
$636.19, late stage
BCRL = $3124.92
Women w/LY tend
to have higher
levels of
psychological,
functional, sexual
& social morbidity
Greater disability is
reported in women
who have > pain,
passive/avoidant
coping styles, poor
support systems, &
LY in dominant
hand
Tx of LY should
consider
psychological wellbeing (counseling,
support groups,
role playing,
behavioral

Limited number of
references
Minimal intext
citations, majority of
them are the authors
own previous article
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Shah et al.,
2012,
Breast Jnl,
US

To summarize
recent data on
BCRL to provide
recommendations
to patients &
health care
providers

Nonsystematic
Review
Level V
N/A

N/A

Current trends:
Dx: CM, VD, selfassessment, BIS
perometry
Tx: compression,
pharmacology,
CDT, multimodality
Risk factors: ALND,
chemotherapy,
regional node
irradiation, radiation
therapy
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techniques &
pharmacology)
BCRL is more
prevalent than
generally thought,
even after less
morbid axillary
surgery is
performed
BCRL can be
identified earlier
w/newer dx tools,
may be used to
prevent chronic LY

O= Rates of BCRL,
Dx of LY, tx of LY,
risk reduction

Assessment aids
should be used
before & after
therapy for all @
risk patients
Data for optimal tx
strategies are
limited, but CDT
had significant
support

Tx= Prospective
surveillance
approach for early
detection &
intervention of LY

LY is a major
concern for BC
patients, they fear
its development

Brief analyses of the
literature
Very little mention
of exercise
interventions for
LY, which there
were some studies
looking at it during
this time

Outcome : Risk Factors and Models of Care
O’Toole et
al.,
2013,
Crit Rev
Oncol
Hematol,
US

To emphasize the
need for more
Level I evidence
& suggest a
surveillance
program

Nonsystematic
Review
Level V
N/A

Extensive searching of websites &
brochures was mentioned

O=
Risk factors: ALND,
radiation,
chemotherapy, high
BMI
QOL: fear & body
image

Inconsistencies
regarding
appropriate timing
& intervention for
LY, no standard
approach to
measurement

The accuracy of
websites &
brochures may
impact the reliability
& validity of their
analysis
Mentioned an
extensive literature
search but gave no
specifics about it
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Controversies:
definition of LY,
measurement
methods, timing,
management of LY

Keeley, V.,
2017,
Curr
Opinon,
UK

To focus on
current & new
developments that
are relevant to
clinical practice

Nonsystematic
Review
Level V
N/A

N/A

O=
Risk factors
Early detection &
intervention
techniques
Causes of severe LY
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Want to implement
a prospective
surveillance
approach w/ a
randomized phase
III trial to provide
level I evidence for
early intervention
of LY
Common risk
factors associated
w/LY were: BMI,
ALND, > lymph
node dissection,
sedentary life styles
& history of other
cancers
New possible tx for
LY include:
docetaxel,
lymphaticovenular
anastomosis,
liposuction, &
subcutaneous
needle drainage
Germ line &
somatic mutations
have become
proposed causes for
severe LY
There needs to be
more research on
new & emerging
detection & tx of
LY

Mainly focused on
new treatments &
causes of LY, very
little discussion on
trends on detection
or risk factors
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Ostby et al.,
2014,
Jrnl
Personalized
Med,

To review the
current research
& to support the
need for a BCRL
surveillance
program

Nonsystematic
Review
Level V
Pyramid
N/A

N/A

O=
Risk factors
Forms of tx for LY
Preventative
interventions
Cost of traditional &
prospective models

USA
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Common risk
factors seen in the
literature are BMI,
radiation therapy,
sedentary lifestyle,
ALND, BC surgery
& comorbidities

Some of the
references were 16 +
years old. May need
to redefine current
w/ research

Txs included
compression
bandaging, surgery,
exercise, as well as
adjuct therapies
(CDT, low-level
laser therapy,
alternative
medicine)
A multidisciplinary
surveillance
approach should be
implemented for
the tx of BCRL

Gerber et al.,
2012,
Cancer,
US

To review
healthcare models
for cancer,
provide an
overview of
current care plans,
& how to
incorporate a

Nonsystematic
Review
Level V
Pyramid
N/A

N/a

O= Models for
chronic issues:
Chronic care model
& Shared care
model
Models for BC:
Survivorship care
plans

A prospective
surveillance model
may cost more
initially; however,
it can save money
in the future &
could improve
patient QOL
Prospective
surveillance model
provides many
elements that are
mentioned in the
Institute of
Medicine’s goals

Very little
recommendations on
how to implement
the prospective
surveillance model
Integration of the
prospective
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prospective
surveillance
program into
cancer tx models
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The health models
are missing
elements that the
prospective
surveillance model
can provide
This model needs
to be integrated
into current models
to identify
impairments sooner

surveillance model
was proposed for
only one type of
model of care
(survivorship care)
Very strong survivor
language, which
may appear as bias
towards the
survivorship model

Systematic Reviews
Outcome : Treatments for LY
Shah et al.,
2016,
Cancer Med,

To perform a
literature review
regarding early
detection &
intervention of
BCRL

Literature
Review
Level I
E1/D1/O1

N = 13 studies. 3 RCTs, 4
prospective studies & 6 retrospective
studies
I= Studies in English evaluating
patients
treated for breast cancer w/some
form of early
LY intervention &/or diagnostic
assessment
between 1990 & 2015

US

E= Were not specified

Stuiver et
al.,
2015,

To assess the
effectiveness of
conservative
interventions for
preventing LY

Systematic
Review
Level I
E1

N= 10 RCTs
I= RCTs that reported 2˚ LY as
outcome, compared usual tx/placebo
to conservative tx.

Searched Medline &
Pubmed for articles.
Search terms & how
articles were
evaluated was
provided
O=
Tx: MLD, exercise,
education,
physiotherapy,
surveillance,
compression sleeves
Volume changes in
UE
Dx: Optoelectronic
perometry, Dual
energy x-ray
absorptiometry, BIS,
CM were used in the
various studies
Tx= Gave data bases
used for searches,
Psychinfo, PEDro,
CENTRAL,
CINAHL, WHO,
MEDLINE,

Some support for
early LY tx (two
RCTS)
There is a need to
form a surveillance
program for LY
management
New diagnostic
techniques have
made early
intervention for LY
possible

Conflicting results
for MLD, no
conclusions can be
drawn for its
effectiveness

The RCTs had a
small sample size
Sensitivity of
diagnostic tests
varied
No comparison
between the models
(surveillance &
intervention)
Exclusion criteria
were not specified

# of studies
reviewed was small
None looked @
effectiveness of
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Cochrane
Database
Sys Rev,
Netherlands

McNeely et
al.,
2010,
Cochrane
Database of
Sys Rev,
Canada

To review RCTs
that examined the
effectiveness of
exercise on
improving,
preventing &
minimizing UE
dysfunction from
BC

Systematic
Review
Level I
E1

Studies w/both sexes & all ages, nonpharmacological/surgical tx
(exercise, patient education, MLD,
compression), looked @ LY
occurrence, QOL, pain, function

EMBASE, CBCG.
The process for
selecting and
reviewing articles
was described

E= Trials w/patients w/recurrence,
surgical/pharmacological
interventions, lower extremity LY

O= Effectiveness of
conventional tx,
occurrence of LY in
UE

N= 24 RCTs
I= RCTs that examine the
effectiveness & safety of exercise for
UE dysfunction
E= Exercise studies that included
cancers other than BC, non RCTs
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Resistance training
does not ↑ risk of
LY
Immediate post-op
start of shoulder
exercises leads to
better function in
the short term (6
months)

Tx= Gave key terms
used in search.
Searched PubMed,
PEDro, Medline,
Embase, LILACS,
grey literature,
SIGLE, reference
lists of articles
chosen & Cochrane
BC group
specialized register

Early exercise
programs in the
early weeks postop were effective
@ improving
shoulder flex & abd
More structured
post-op exercise
programs were
more beneficial
than usual care

2 authors screened
the articles to
determine if they
were retained. 3
authors rated quality
of studies on a 6point scale.
Performed metaanalyses when
possible

No evidence for ↑
risk from exercise
program
w/adjuvant tx
3 studies supported
the use of exercise
programs post
cancer tx for QOL

compression therapy
or education
None of the studies
included
psychosocial
morbidity
(depression/anxiety)
Overall quality of
evidence was low,
due to lack of
blinding in studies
Definition of LY
differed amongst the
studies
Authors were not
able to perform
meta-analyses on
every study
Data pooling
because of outcome
measures,
measurement
methods, & timing
of measurements in
chosen articles
Performed metaanalyses despite
inter-study
heterogeneity
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Fu et al.,
2014,
Oncol
Nursing Soc,
US

To provide
healthcare
providers
w/evidence basedclinical guidelines
for current tx of
LY

Systematic
Review
Level I
D1

N= 75 articles, between Jan 2009 &
Feb 2014
I= Full research report, systematic
review, guideline or meta-analysis,
must report results of LY
measurement, must look at an
intervention (risk
reduction/prevention/management),
study sample must include patient’s
w/cancer
E= Duplicates, studies that don’t
meet inclusion criteria, qualitative
studies, case reports, studies on
vascular changes, no grey literature,
non-systematic reviews,
nonreferenced articles, abstracts,
review guidelines, dissertations &
secondary data analysis

O= Early vs delayed
exercise, exercise vs
comparison,
exercise vs
comparison during
adjuvant cancer tx,
exercise vs
comparison post-tx
Tx= Gave table of
key search terms
used. Searched
PubMed, CINAHL,
Medline, Cochrane
Database, CancerLit
& National Library
of Medicines
Each article was
assessed
independently by 2
researchers. Articles
were categorized
using ONS PEP
level of evidence
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The use of
complete
decongestive
therapy &
compression
garments had
support from the
highest levels of
evidence
Exercise, early
intervention & tx
are likely to be
effective

Found limited
articles in other
areas besides
complete
decongestive
therapy & full body
exercise (possible
selection bias)
Little explanation
for conclusions on
MLD, pneumatic
compression, &
low-level laser
therapy

O= Evidence for
CDT, compression
garments/bandages,
full-body exercise

Abbreviation Key for Systematic Review Table
ALND = axillary lymph node biopsy, BC = breast cancer, BCRL= breast cancer related lymphedema, BIS = bioimpedance spectroscopy, BMI = body mass
index, CDT = complete decongestive therapy, CM = circumferential measures, Dx = diagnosis/diagnostic, E = exclusion, I = inclusion, LY = lymphedema, MLD
= manual lymph drainage, O = outcomes, QOL = quality of life, Tx = treatment, UE = upper extremity, VD = volume displacement
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Summary of Key Findings:
Summary of Experimental Studies
There is strong evidence that exercise is not contraindicated for clients at risk of
lymphedema (Anderson et al., 2012; Box et al., 2002; Kilbreath et al., 2012; McNeely
et al., 2010; Olivera et al., 2014; Stuiver et al., 2015, Thakur et al., 2016; Torres
Lacomba et al., 2010). Physiotherapy included physical modalities such as massage,
stretching, and compression sleeves. Exercise included various strength training
protocols. There is strong evidence that exercise directly following post-op is
correlated with increased function of the upper extremity for clients at risk of
lymphedema (Kilbreath et al., 2012; McNeely et al., 2010; Stuiver et al., 2015).
There is limited evidence that control groups without exercise interventions and
treatment groups with exercise interventions had similar quality of life outcomes on a
short-term basis (Anderson et al., 2012, Thakur et al., 2016).

Summary of Outcome Studies
There is strong evidence that compression sleeves are a safe early intervention for
treating lymphedema in Stage 0 and Stage 1 (Akita et al., 2017; Kaufman, 2017; Sing
et al., 2013, Stout et al., 2008). There is some evidence that risk factors for
lymphedema development/progression included axillary lymph node removal,
regional nodal irradiation, and increased BMI. There is limited evidence to suggest
that when clients with lymphedema perform occupation based activities, their social
relationships, mental health, performance and satisfaction with occupational
performance improves (Maher & Mendonca, 2017).
Summary of Non-Classifiable Studies
There is strong evidence to implement a surveillance model to increase early
detection and early intervention of lymphedema. Three articles do conclude that a
prospective surveillance model may be more expensive initially, however the longterm health care costs would be less than current traditional models (Otsby et al.,
2014; Sayegh et al., 2017, Stout et al., 2012). One article suggests that the
surveillance method can be integrated into the current models of practice (Gerber et
al., 2012). There is moderate evidence to conclude that BMI, radiation therapy and
method of surgery were risk factors for developing lymphedema (Keeley et al., 2017,
Otsby et al., 2014). There is limited evidence to suggest that the psychological and
psychosocial aspects of lymphedema need to be considered during treatment (Passik
& McDonald, 1998) as well as that the incidence of lymphedema is much greater
than previously thought (Shah et al., 2012).
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Summary of Descriptive Studies
There is strong evidence that compression sleeves and decongestive therapy will be
effective in treating lymphedema (Fu et al., 2014). There is moderate evidence that
exercise and early intervention help prevent the progression of lymphedema (Fu et
al., 2014). Limited evidence exists that BMI, radiation, and axillary lymph node
dissection were risk factors for developing lymphedema (Schmitz et al., 2012, Soyder
et al., 2014).
Implications for Consumers:
There is strong evidence that exercise does not increase risk of lymphedema post-op. Also,
surveillance methods to detect lymphedema at a subclinical stage are supported and should
be discussed with your oncology provider. It is also important to note that fear of developing
lymphedema may impact function more than physical limitations caused by the lymphedema.
Implications for Practitioners:
Pre-operative measurements and surveillance methods are strongly supported in order to
implement early intervention practices. There should be awareness around potential risk
factors and education about signs/symptoms of subclinical lymphedema. Exercise may be
prescribed with a surveillance approach to verify lymphedema is not developing or
progressing. This is important because in most cases education alone was not sufficient in
preventing lymphedema, when compared to treatment groups that received a physical
modality intervention. Additionally, there is strong evidence that compression garments may
prevent lymphedema from progressing to an irreversible stage. Furthermore, practitioners
should consider interventions that may impact psychosocial aspects during lymphedema
treatment.
Implications for Researchers:
Quality of life measures should be included in research investigating lymphedema
management and intervention. Retrospective research of client perspective, e.g, how did they
feel about interventions they received or the lack of, did they receive education on
lymphedema management, how accessible was the education., etc. Additionally, more
research needs to be conducted on lymphedema that is related to other types of cancer and
impacts the lower extremities.
Bottom Line for Occupational Therapy Practice/ Recommendations for Better Practice:
There is no evidence that surveillance methods would be contraindicated for lymphedema
patients. Additionally, there is some evidence that treating lymphedema at a subclinical
stage reduces treatment time and inhibits the progression of lymphedema. In conclusion,
there is potential that surveillance methods, coupled with early intervention, may reduce
overall healthcare costs and maintain a high quality of life for oncology clients.
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Involvement Plan
Introduction
In our meeting with Heidi Shaffer, OTR/L, MSM, CLT-LANA last semester, we presented
the results from our CAT table. The table provided the strongest evidence for surveillance
methods as preventing lymphedema from progressing past Stages 1 and 2. Additionally, there
was strong evidence for the use of compression garments as an early intervention. Furthermore,
strong evidence was found to suggest that exercise was not contraindicated for early treatment of
lymphedema.
We then discussed how our results applied to Shaffer’s setting. We asked Shaffer if
MultiCare was moving towards a surveillance method. She reported that they were moving
towards the implementation of surveillance methods, as supported by the purchase of the L-Dex.
However, she concluded that a surveillance method has not yet been fully implemented. One
barrier to the implementation was the time commitment required to create and implement a
system-wide method. Later, we discussed potential options for knowledge translation. These
included assisting lymphedema lobbyists to further support advocacy for compression garment
coverage by Medicare or creating a system that Shaffer could use to track patient outcomes. This
system could help determine the relationship within MultiCare between time of treatment (Stage
0, 1, 2), length of treatment, modalities, and progression of lymphedema. Additionally, we
wanted to track the financial outcomes of early intervention vs. standard practice within the
MultiCare system. These ideas were discussed with our mentor and our chair and were assessed
based on the semester time constraint limiting what could realistically be completed.
In our follow up meeting with Shaffer during spring semester, she suggested knowledge
translation options that would be most helpful to her. These included submitting our research to
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the International Lymphoedema Framework Conference, a presentation to her supervisor, and a
potential presentation to the team of lymphedema specialists at one of their quarterly meetings.
With the course mentor’s guidance, the authors discussed creating a template for tracking
outcomes to share with Shaffer, her supervisor, and her team. In conclusion, our knowledge
translation included submission of an abstract to the International Lymphoedema Framework
Conference, a verbal presentation to Shaffer and her supervisor and a PowerPoint that was made
available to the rest of Shaffer’s team and other providers who may be interested in the research.
We conducted a survey to help evaluate the outcomes of our presentation and the proposed
tracking outcomes data sheet.
Context
Our collaborator is employed by MultiCare which is a nonprofit organization in
Washington State that is a comprehensive healthcare system. There are currently seven
MultiCare hospitals centered in the South Sound. Shaffer is employed at the MultiCare Women’s
Health and Wellness Center, Gig Harbor Medical Park. Oncology services are also available at
the Gig Harbor location. Having multiple specialties within the same physical location ensures
greater potential for fluid knowledge translation.
Shaffer is an OTR/CLT/LANA who supports the philosophy of early intervention in
lymphedema treatment. She is a part of a lymphedema specialist team. This team is composed of
OTs and PTs and is supervised by Sherri Olsen, OTD, MBA. Shaffer expressed that Olsen
actively seeks out information that would impact their client outcomes. Olsen’s desire to support
best practice of lymphedema treatment supported our knowledge translation outcomes. Shaffer’s
manager has a greater impact on the MultiCare system and therefore, there was a greater
potential for dissemination of our research findings.
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Tasks/Products and Target Dates:
NOTE: Date change for presentation of findings to supervisor Sherri Olsen, moved the dates for other tasks into late
March.
Task Product (1a-f)

Deadline

Steps w/ dates to achieve the final
outcome

How items were achieved w/dates

Abstract to International
Lymphoedema
Framework

2/14/18

● Determine the requirements for
submitting abstract (2/11-2/12)
● Meet to write up the abstract for
submission (2/12-2/13)
● Submit the abstract (2/14)

● Abstract was submitted to the International
Lymphoedema Framework on 2/14/18
● Abstract was sent to George and Jenny on
3/26/18
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Tracking Outcomes
Data Sheet

3/19/18*

● Create a potential template and
meet with George/Jenny to discuss
(3/5/18*)
● Send Shaffer potential template
and discuss how to best implement it
(3/6/18*)
● Work it into the
presentation/introduce it to the
lymphedema team (3/19/18*)

● Draft template for tracking outcomes
completed on 2/21/18
● Meeting w/George to discuss data sheet on
3/26/18
● Finalized outcomes sheet presented to
Shaffer’s supervisor on 4/6/18
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Presentation to
supervision and
lymphedema team

● Talk to Shaffer about the logistics
of the presentation (2/12/18)
● Compile the main points of our
evidence and main topic for in-service
(3/1/18)
● Begin creating a presentation
(3/2/18)
● Provide Shaffer with a draft
presentation for approval (3/20/18*)
● Meet with Shaffer’s supervisor to
present findings (3/28/18*)
● Present findings to lymphedema
team (4/1/18*)
● Survey regarding presentation
and tracking outcomes data sheet
(4/2/18)

*Dates are subject to change until Shaffer confirms date for next team meeting.
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● Email communication about meeting
logistics sent to Shaffer on 2/21/18
● Compiled main points of evidence and
created draft presentation on 3/19/18
● Outcomes survey created on 3/19/18
● Meeting w/George to review outcomes
survey on 3/26/18
● Met w/Olsen on 4/6/18 to discuss CAT
findings. Meeting was moved due to logistical
reasons and scheduling
● Email sent to Olsen w/finalized PowerPoint
to share w/the lymphedema team as well as
outcome survey and CAT references on 4/6/18
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Activities and Products Completed
Our knowledge translation consisted of three main components. The first component was
to submit an abstract explaining our research to a lymphedema conference, per Shaffer’s request.
Shaffer felt that this was very important and was something she had wanted previous groups to
do as part of their knowledge translation. When looking for conferences to submit to, we found
that the Annual Lymphedema Conference was not in session this year. However, the
International Lymphoedema Framework Conference was taking place this summer in the
Netherlands. We discussed this option with Shaffer, and she encouraged us to submit an abstract.
The process for writing and submitting the abstract was challenging. The turn-around time
between email communications with Shaffer and the deadline for submitting the abstract was
narrow. Additionally, the time zone difference added extra complications for submission. The
abstract needed to be 250 words and was to be submitted by February 14th, 2018 at midnight
Netherlands time. Due to these complications, the abstract was written and submitted to the
conference without further discussion with our project chair or mentor. After submitting the
abstract, we notified the project chair and mentor and discussed the logistics of the situation.
The second component of our knowledge translation was to create an outcomes data
tracking sheet to monitor lymphedema client outcomes, and determine the referral process for
lymphedema clients at MultiCare. In order to create this data sheet, we had to consider the
pertinent information practicing clinicians would collect from clients and how this information
would be synthesized and analyzed. A large purpose of the survey was to determine who was
referring lymphedema clients, when the referral was made, the time between referrals and initial
occupational therapy evaluations as well as what type of education or treatment was provided to
the client. The draft template was then presented to both our research chair and mentor for
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feedback. The final template was presented to Olsen, the supervisor for the lymphedema team at
MultiCare, during the meeting on April 6th. Olsen commented that one of the other lymphedema
therapists had developed a similar Excel spreadsheet to compile outcome data at the beginning of
this year. At the end of the meeting, Olsen commented that she would take this template to that
therapist and discuss further development of outcomes tracking.
The final component for our knowledge translation was to present our findings to Olsen,
Shaffer’s supervisor. The presentation consisted of a condensed form of our CAT table including
our abstract, an overview of the development of our research question, the summaries of the
evidence, and the implications of our findings. The PowerPoint was sent to Olsen in advance to
facilitate an informed discussion rather than a slide-by-slide presentation. During the discussion,
Olsen appeared to be very open to the ideas presented and interested in what the authors had
found. She asked us questions regarding the various levels of evidence and recent research.
While discussing the current referral process for lymphedema clients at MultiCare, Olsen
reported that there is an oncologist who is referring clients on a regular basis, but that it is
challenging to get the surgical oncologists to refer clients preoperatively. She commented that a
lack of preoperative and limited postoperative interactions with clients at risk of lymphedema, is
the greatest barrier to implementing early intervention strategies. At the end of the presentation,
we discussed how to best disseminate this information to the MultiCare team. It was determined
that we would send Olsen a list of our CAT references, our PowerPoint and survey. She would
then provide that information to the rest of the team.
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Outcomes and Effectiveness
Outcomes of the knowledge translation were measured with different tools. The
effectiveness of our conference submitted abstract could not be evaluated due to its denial into
the conference. No reviewer feedback was provided upon denial to use as outcome data. Upon
reflection, the submission of the abstract was measurable as a group learning opportunity. There
was a short deadline for abstract submission that required quick group collaboration and lack of
editing or revision from our collaborator, mentor, or chair. Additionally, we submitted the
abstract with the intent to present comparatively to only submitting as a poster presentation. This
preference could have impacted the revision for submission into the conference.
The data sheet we created to track outcomes of lymphedema clients was presented to
Olsen as a possible way to support the implementation of a surveillance method. She disclosed a
peer had created an Excel tracking sheet and that she would consult with that individual to
consider the addition of outcomes we had considered. For example, time between referral date
and an appointment with a lymphedema therapist.
The in-service was measured by direct conversation throughout the presentation and a
follow-up survey that will be collected from Olsen via email. From direct feedback, Olsen
reported the in-service did provide novel ideas that she was excited to implement. For example, a
possible video for pre-op education that would support a surveillance method treatment
approach. In the follow-up survey, Olsen indicated that she did learn new information including
the role of surveillance methods in the MultiCare system. Additionally, she found the most
pertinent and impactful information in our discussion to be about using technology for educating
clients as well as the reinforcement that exercise is supported for daily function in clients at risk
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of developing lymphedema. Furthermore, Olsen commented that future UPS research groups
could assist in creating client education videos.
Evaluation of the Overall Process of Project
Our research group was particularly excited for our research topic especially because we
had been exposed to Shaffer and her clinical reasoning during a guest lecture in biomechanics.
We originally wanted to follow-up on last year’s project, however after meeting with Shaffer our
research took a different direction while still supporting Shaffer’s current needs. Research for our
topic was fairly accessible, as related to breast cancer. Originally, with Shaffer’s guidance we did
want to include research of various cancer, however the research emphasized breast cancer even
without using breast cancer as a search term. One minor challenge faced during the research
phase was observing the trends in lymphedema research. Our research question specifically
focused on early intervention however, trends in lymphedema research included many risk factor
studies. Having a support team of faculty to problem solve with was supportive in addressing this
challenge. Through this project we were able to engage with clinicians and potentially set-up
future student research groups to contribute to lobbying for lymphedema management,
specifically supporting treatment that would decrease the progression of lymphedema to an
irreversible stage.
At the beginning of the process our group of three established communication around
roles we would each fill to facilitate the efficiency of the group as we moved through the year
long process. Setting these roles ahead of time, in addition to open communication throughout
the process facilitated completing the parts of the project in a timely manner. Additionally, our
meetings were tracked on a data sheet to support team member accountability and as a reflection
of how much time we were committing to the project.
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We feel accomplished in completing our CAT, especially after our meeting with Olsen.
Seeing all of our hard work being well received and valued by a practicing clinician who has
potential to effect change on a systems level, was rewarding and motivating. This project was
eye-opening to the vast opportunities we will have as future occupational therapists and we could
not be more excited to engage in our new role as entry-level practitioners.
Recommendations for the Future
One of our findings suggested the potential for implementation of surveillance methods
as it is not contraindicated by available research. This lead to our group developing an outcomes
tracking worksheet which could be utilized to understand trends in lymphedema referrals over
time. Of particular interest, is tracking elements which may support wider use of preventive
lymphedema intervention as opposed to treating lymphedema once it has already progressed past
Stage 1. During the meeting with Olsen it was discovered there is currently a physical therapist
in oncology at MultiCare who has been informally tracking clinical outcomes since the start of
2018. The value of clinical outcomes tracking is frequently overlooked because of time
constraints evident in medical workplaces. Future student research could be directed towards
supporting widespread implementation of an outcomes tracking system within a large scale
medical network like MultiCare. If students were to dedicate research in this direction they may
be able to access the outcomes data currently being tracked by the physical therapist mentioned
above. Furthermore, research groups may be able to analyze this data in effort to extrapolate
meaning from the synthesis of currently tracked outcomes data.
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Appendix A
Outcomes Data Tracking Sheet
Oncology referral date:

Referring physician/location:

__PCP __Surgeon __Oncology
__Other:________
Oncology appointment date:

Referral date to OT:
OT appointment date:
Bioimpedance Score
Intake:
Stage of Lymphedema:
0 1 2 3
Follow-up 1:
Stage of Lymphedema:
0 1 2 3
Follow-up 2:
Stage of Lymphedema:
0 1 2 3
Follow-up 3:
Stage of Lymphedema:
0 1 2 3
OT treatment plan:
□Education
□Compression garment: OTC/Custom
□Home program
__Occupation __Self-massage
__ROM (Passive / Active) __
Strengthening
□Other:______________
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Appendix B
Knowledge Translation Follow-up Survey
1. Was there new information presented to you today?
Y/N If yes, please describe.

2. What was the most pertinent information presented today?

3. Is there potential for this information to be impactful to the MultiCare system?
If yes, how so? What are potential support/barriers?

4. Has a past research group from the University of Puget Sound created an impactful
change within the MultiCare organization?
Y / N Briefly describe

5. What next steps could student researchers take to support the implementation or
translation of this information?
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